Product Details- Tirzepatide Nasal Spray

Tirzepatide nasal spray is a research-grade formulation containing a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

Structurally, Tirzepatide is a 39-amino acid peptide engineered for enhanced stability and bioactivity in experimental models. It is of interest in scientific research for its potential effects on metabolic signaling pathways and receptor-mediated mechanisms.

The nasal spray format is one of several delivery methods used by researchers to study the compound’s properties under laboratory conditions

This product is intended for laboratory research purposes only. It is not intended for human consumption, medical, or diagnostic use.

How Does Tirzepatide Work?

In preclinical research environments, Tirzepatide has been studied for its interaction with the GIP and GLP-1 receptors, which play roles in metabolic regulation.

The nasal spray delivery system is utilized in experimental protocols to explore alternative administration routes that bypass gastrointestinal degradation and allow for systemic absorption via the nasal mucosa. 

These studies aim to better understand Tirzepatide’s pharmacological profile and its behavior under controlled research conditions.

Properties of Tirzepatide

• Molecular Formula: C225H348N48O68 
• Synonyms: GLP-1 and GIP nasal spray, Dual agonist nasal spray, Tirzepatide peptide spray
• IUPAC Name: 20-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]…
• Molecular weight: 4813.527 g/mol
• CAS Number: 2023788-19-2

Research Findings on Tirzepatide 

Tirzepatide has been examined in scientific research for its effects on metabolic signals and related biological pathways. In research studies, tirzepatide was observed to produce greater changes in metabolic markers, including glycaemic parameters and body weight indicators, compared to control conditions under controlled experimental settings. These outcomes were observed in analyses of pooled trial data. This demonstrates reproducible effects on key metabolic endpoints across different study designs and dose groups.

Preclinical and early‑phase studies also indicate that tirzepatide influences metabolic processes such as energy expenditure and fuel utilization. Experimental observations in metabolic models showed increases in fat oxidation and changes in energy balance signals. These findings help clarify how tirzepatide affects complex metabolic pathways in research settings.

Note: Tirzepatide is FDA-approved under the brand name Mounjaro for the management of type 2 diabetes. It is also available for research purposes, and its use in laboratory or experimental studies must follow proper research regulations and guidelines.

Why Choose BehemothLabz to Buy Tirzepatide Nasal Spray?

BehemothLabz provides Tirzepatide nasal spray as a high-quality research product for use in non-clinical settings. Each batch undergoes thorough quality assurance testing and third-party verification to ensure purity, identity, and consistency.

BehemothLabz is dedicated to supplying reliable research compounds that meet the needs of investigators studying peptide pharmacology, receptor activity, and related biochemical processes.

With a strong focus on transparency and scientific integrity, BehemothLabz has become a trusted resource in the research community.

Disclaimer

Please make sure you go through the Terms and Conditions, and please familiarize yourself with them as they are important. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.

Buying the product means you agree to our Terms and Conditions. You can contact our awesome customer service team at support@behemothlabz.com if you are not fully satisfied with the product.

ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

Reference Links

PubChem. (n.d.). Tirzepatide. Pubchem.ncbi.nlm.nih.gov. https://pubchem.ncbi.nlm.nih.gov/compound/156588324

Karagiannis, T., Avgerinos, I., Liakos, A., Del Prato, S., Matthews, D. R., Tsapas, A., & Bekiari, E. (2022). Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia, 65(8), 1251–1261. https://doi.org/10.1007/s00125-022-05715-4

Ravussin, E., Sanchez-Delgado, G., Martin, C. K., Beyl, R. A., Greenway, F. L., O’Farrell, L. S., Roell, W. C., Qian, H.-R., Li, J., Nishiyama, H., Haupt, A., Pratt, E. J., Urva, S., Milicevic, Z., & Coskun, T. (2025). Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation. Cell Metabolism. https://doi.org/10.1016/j.cmet.2025.03.011